Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Rockstar Energy founder seeks CEO role at Celsius Holdings
• Ford Plans New Four-door Version Of Mustang - WSJ
• Chevron Sees Lower End Of $18-$19B Capex Guidance At Yr End - Bloomberg